Received Nov 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 75DA | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Itching; This non-serious case was reported by a consumer and described the occurrence of itching in a 78-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On 28-MAY-2025, an unknown time after receiving Shingles vaccine, the patient experienced itching (Verbatim: Itching). The outcome of the itching was not resolved. It was unknown if the reporter considered the itching to be related to Shingles vaccine. It was unknown if the company considered the itching to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 23-NOV-2025 The patient self-reported this case for himself.